Valneva SE
PAR:VLA

Watchlist Manager
Valneva SE Logo
Valneva SE
PAR:VLA
Watchlist
Price: 3.82 EUR 1.17% Market Closed
Market Cap: 656.9m EUR

Valneva SE
PP&E Net

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Valneva SE
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Valneva SE
PAR:VLA
PP&E Net
€147.4m
CAGR 3-Years
-5%
CAGR 5-Years
17%
CAGR 10-Years
11%
Nanobiotix SA
PAR:NANO
PP&E Net
€4.9m
CAGR 3-Years
-13%
CAGR 5-Years
-12%
CAGR 10-Years
6%
Inventiva SA
PAR:IVA
PP&E Net
€5m
CAGR 3-Years
-7%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Cellectis SA
PAR:ALCLS
PP&E Net
$70.2m
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
38%
DBV Technologies SA
PAR:DBV
PP&E Net
$16.6m
CAGR 3-Years
-4%
CAGR 5-Years
-17%
CAGR 10-Years
22%
Eurobio Scientific SA
PAR:ALERS
PP&E Net
€12.1m
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
27%
No Stocks Found

Valneva SE
Glance View

Market Cap
620.4m EUR
Industry
Biotechnology

Valneva SE is a biotech company. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 722 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

VLA Intrinsic Value
11.85 EUR
Undervaluation 68%
Intrinsic Value
Price

See Also

What is Valneva SE's PP&E Net?
PP&E Net
147.4m EUR

Based on the financial report for Jun 30, 2025, Valneva SE's PP&E Net amounts to 147.4m EUR.

What is Valneva SE's PP&E Net growth rate?
PP&E Net CAGR 10Y
11%

Over the last year, the PP&E Net growth was -6%. The average annual PP&E Net growth rates for Valneva SE have been -5% over the past three years , 17% over the past five years , and 11% over the past ten years .

Back to Top